CRISPR Therapeutics AG (CRSP)
USD 41.06
(-8.0%)
USD 41.06
(-8.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 371.2 Million | 436 Thousand | 913.08 Million | 543 Thousand | 289.59 Million | 3.12 Million |
| Cost of Revenue | 130.25 Million | 110.25 Million | 17.95 Million | 269.4 Million | 179.36 Million | 113.77 Million |
| Gross Profit | 240.95 Million | -109.81 Million | 895.12 Million | -268.86 Million | 110.22 Million | -110.64 Million |
| Operating Expenses | 463.49 Million | 563.34 Million | 539.55 Million | 354.97 Million | 242.85 Million | 162.06 Million |
| Selling, General and Administrative Expenses | 76.16 Million | 102.46 Million | 102.8 Million | 88.2 Million | 63.48 Million | 48.29 Million |
| Research and Development Expenses | 387.33 Million | 461.64 Million | 438.63 Million | 266.94 Million | 179.36 Million | 113.77 Million |
| Other Expenses | - | -762 Thousand | -1.88 Million | -176 Thousand | 20.56 Million | -5.48 Million |
| Cost and Expenses | 593.74 Million | 673.59 Million | 539.55 Million | 354.97 Million | 242.85 Million | 162.06 Million |
| Operating Income | -222.53 Million | -673.16 Million | 373.52 Million | -354.43 Million | 46.74 Million | -158.94 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 2.88 Million | -325 Thousand | 1.87 Million | 809 Thousand | 448 Thousand | 553 Thousand |
| Earnings before Tax | -150.72 Million | -650.5 Million | 379.53 Million | -348.05 Million | 67.3 Million | -164.42 Million |
| Net Income | -153.61 Million | -650.17 Million | 377.66 Million | -348.86 Million | 66.85 Million | -164.98 Million |
| Earnings Per Share Basic | -1.94 | -8.36 | 4.97 | -5.29 | 1.23 | -3.44 |
| Earnings Per Share Diluted | -1.94 | -8.36 | 4.70 | -5.29 | 1.17 | -3.44 |
| Weighted Average Shares Outstanding | 79.22 Million | 77.74 Million | 75.94 Million | 65.94 Million | 54.39 Million | 47.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.22 Million | 77.74 Million | 80.39 Million | 65.94 Million | 56.93 Million | 47.96 Million |
| Gross Margin | 0.65 | -251.87 | 0.98 | -495.15 | 0.38 | -35.42 |
| EBIT Margin | -0.55 | -1543.95 | 0.41 | -635.82 | 0.16 | -50.88 |
| Profit Margin | -0.41 | -1491.23 | 0.41 | -642.48 | 0.23 | -52.81 |
| EBITDA | -202.7 Million | -648.98 Million | 391.48 Million | -345.25 Million | 51.46 Million | -155.42 Million |
| Earnings Before Tax Margin | -0.60 | -1543.95 | 0.41 | -652.73 | 0.16 | -50.88 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 602 Thousand | 517 Thousand | 504 Thousand | 370 Million | 200 Million | - |
| Cost of Revenue | 11.15 Million | 56.97 Million | 51.79 Million | 130.25 Million | 20 Million | 23.42 Million |
| Gross Profit | -10.55 Million | -56.45 Million | -51.29 Million | 239.75 Million | 180 Million | -23.42 Million |
| Operating Expenses | 99.57 Million | 94.8 Million | 89.29 Million | 462.28 Million | 110.41 Million | 108.98 Million |
| Selling, General and Administrative Expenses | 17.41 Million | 19.48 Million | 17.95 Million | - | 16.47 Million | 18.29 Million |
| Research and Development Expenses | 82.16 Million | 75.32 Million | 71.33 Million | - | 95.14 Million | 90.69 Million |
| Other Expenses | - | 26.13 Million | 24.72 Million | 71.81 Million | 19.99 Million | 20.67 Million |
| Cost and Expenses | 110.73 Million | 151.77 Million | 141.09 Million | 592.53 Million | 130.41 Million | 132.41 Million |
| Operating Income | -110.13 Million | -151.26 Million | -140.58 Million | -222.53 Million | 69.58 Million | -132.41 Million |
| Interest Expense | - | - | - | - | 17.79 Million | - |
| Income Tax Expense | -876 Thousand | 1.28 Million | 724 Thousand | 2.88 Million | 233 Thousand | -412 Thousand |
| Earnings before Tax | -85.06 Million | -125.12 Million | -115.86 Million | -150.72 Million | 89.58 Million | -111.74 Million |
| Net Income | -85.94 Million | -126.4 Million | -116.59 Million | -153.61 Million | 89.34 Million | -112.15 Million |
| Earnings Per Share Basic | -1.01 | -1.49 | -1.43 | - | 1.12 | -1.41 |
| Earnings Per Share Diluted | -1.01 | -1.49 | -1.43 | - | 1.10 | -1.41 |
| Weighted Average Shares Outstanding | 85.23 Million | 84.92 Million | 81.79 Million | 79.22 Million | 79.68 Million | 79.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 85.23 Million | 84.92 Million | 81.79 Million | 79.22 Million | 81.32 Million | 79.41 Million |
| Gross Margin | -17.53 | -109.21 | -101.78 | 0.65 | 0.90 | - |
| EBIT Margin | -182.94 | -283.20 | -269.35 | - | 0.37 | - |
| Profit Margin | -142.76 | -244.50 | -231.33 | -0.42 | 0.45 | - |
| EBITDA | -110.13 Million | -146.41 Million | -135.75 Million | - | 74.48 Million | -132.41 Million |
| Earnings Before Tax Margin | -182.94 | -292.57 | -278.94 | -0.60 | 0.35 | - |
KSRYY
DX-PC
BTSG
GANECOS
3077
9272